Literature DB >> 9291384

Cerebral fat embolism studied by magnetic resonance imaging, transcranial Doppler sonography, and single photon emission computed tomography: case report.

H Satoh1, K Kurisu, M Ohtani, K Arita, S Okabayashi, T Nakahara, K Migita, K Iida, K Kuroki, N Ohbayashi.   

Abstract

Cerebral fat embolism syndrome is an uncommon complication of trauma. We present a patient who developed cerebral fat embolism syndrome secondary to long-bone fractures. Although computed tomography of the brain failed to show any intracranial lesion, magnetic resonance imaging (MRI) detected scattered, high-signal-intensity lesions on T2-weighted images. 99mTc-d, 1-hexamethyl-propylene amine oxine single photon emission computed tomography (99mTc-HMPAO SPECT) and transcranial Doppler sonography (TCD) demonstrated low cerebral blood flow in the acute stage. MRI, 99mTc-HMPAO SPECT, and TCD correlated well with the clinical course of cerebral fat embolism syndrome.

Entities:  

Mesh:

Year:  1997        PMID: 9291384     DOI: 10.1097/00005373-199708000-00023

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  5 in total

1.  Clinical and radiographic improvement following cerebral fat emboli.

Authors:  Anand I Rughani; Jeffrey E Florman; David B Seder
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

2.  MR imaging of the brain in fat embolism syndrome.

Authors:  Joseph Jen-Sho Chen; James C Ha; Stuart E Mirvis
Journal:  Emerg Radiol       Date:  2007-10-13

3.  Cerebral fat embolism in the absence of a long bone fracture: A rare case report.

Authors:  James B Fowler; Brian Fiani; Kasra Sarhadi; Vladimir Cortez
Journal:  Surg Neurol Int       Date:  2021-03-02

4.  Fat embolism syndrome.

Authors:  Jacob George; Reeba George; R Dixit; R C Gupta; N Gupta
Journal:  Lung India       Date:  2013-01

5.  Imaging findings of cerebral fat embolism syndrome: a case report.

Authors:  Yali Wang; Zhihua Si; Jingzhe Han; Shuangqing Cao
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.